3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
9
Phase 2
4
Phase 3
2
Phase 1/2
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
1
Conditions
Leukemia, Myeloid, Acute
2
Myelodysplastic Syndromes
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia
1
Interventions
Cytarabine
89
Daunorubicin
45
Azacitidine
43
Idarubicin
27
venetoclax
26
fludarabine
26
Etoposide
25
Cyclophosphamide
25
Mitoxantrone
22
Decitabine
19
Busulfan
19
Methotrexate
16
Gemtuzumab
14
Granulocyte Colony-Stimulating Factor
12
Whole-Body Irradiation
10
Peripheral Blood Stem Cell Transplantation
10
Melphalan
10
gilteritinib
9
Filgrastim
9
fludarabine phosphate
8
Tacrolimus
8
Mycophenolic Acid
8
Cyclosporine
8
Tretinoin
7
Radiotherapy
7
Drug Therapy
7
Observation
6
Homoharringtonine
6
Antilymphocyte Serum
6
quizartinib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Leukemia, Myeloid, Acute
×
pevonedistat
×
Clear all
NCT03268954
2025-10-29
PANTHER
Takeda
Phase 3
Completed
454 enrolled
41 charts
NCT04090736
2025-03-17
PEVOLAM
PETHEMA Foundation
Phase 3
Active not recruiting
302 enrolled